期刊文献+

TGFβ1和AT1R基因多态性与乙肝肝硬化遗传易感性及临床表型的关联研究 被引量:7

The association of TGFβ1 and AT1R gene polymorphisms with hereditary susceptibility and clinical phenotype of HBV-induced liver cirrhosis
原文传递
导出
摘要 目的探讨与宿主肝纤维化及门脉高压形成相关的转化生长因子β1(transforming growth fac-tor beta1,TGFβ1)和Ⅰ型血管紧张素Ⅱ受体(angiotensinⅡ type 1 receptor,AT1R)基因多态性与乙肝肝硬化遗传易感性及临床表型的关系。方法应用PCR-RFLP对102例乙型肝炎后肝硬化患者和106名随机抽样的无亲缘关系的健康献血者分别检测TGFβ1启动子区-509C/T、AT1R1166A/C基因多态性。结果肝硬化组TGFβ1启动子区-509C/T纯合子CC的基因型频率明显高于对照组(P〈0.05);肝硬化Child-PughC级组-509C/T位点CC基因型分布频率明显高于B级和A级组(P〈005);AT1R1166A/C基因型和等位基因频率在对照组和肝硬化组之间差异均无统计学意义(P〉0.05)。结论TGFβ1启动子区-509C/T基因多态性与乙型肝炎后肝硬化遗传易感性有关,并与肝硬化严重程度密切相关,AT1R1166A/C基因多态性可能与乙型肝炎后肝硬化遗传易感性无关。 Objective To investigate the association of TGFβ1 and AT1R gene polymorphisms with hereditary susceptibility and clinical phenotype of HBV-induced liver cirrhosis. Methods Peripheral blood samples were collected from 102 patients with HBV-induced liver cirrhosis and 106 healthy blood donors. The polymorphisms of the promoter site -509C/T of TGFβ1 and 1166A/C of AT1R gene were determined by PCR-RFLP. Results The frequency of the homozygote CC of - 509C/T of TGFβ1 gene in the group of liver cirrhosis was higher than that the control group ( P 〈 0.05 ) ; and the frequency rate of homozygote CC was higher in group C than in group A and group B of liver cirrhosis ( P 〈 0.05), but there was no significant difference in allele frequency among these group (P 〉 0.05). There was no significant difference in genotypes and allele frequency of AT1R gene 1166A/C between the liver cirrhosis group and the control group ( P 〉 0.05). Conclusion The polymorphism of the promoter site - 509C/T of TGFβ1 gene is associated with hereditary susceptibility to liver cirrhosis and severity of HBV-induced liver cirrhosis; the polymorphism of AT1R gene 1166A/C is not associated with hereditary susceptibility to HBV-induced liver cirrhosis.
出处 《中华医学遗传学杂志》 CAS CSCD 北大核心 2007年第3期298-301,共4页 Chinese Journal of Medical Genetics
关键词 乙型肝炎 肝硬化 转化因子β1基因 Ⅰ型血管紧张素Ⅱ受体 基因多态性 hepatitis B liver cirrhosis transforming growth factor beta 1 gene angiotensin Ⅱ type 1 receptor gene gene polymorphism
  • 相关文献

参考文献7

二级参考文献35

  • 1DU Wei-Dong,ZHANG Yue-E,ZHAl Wei-Rong and ZHOU Xiao-Mei(Department of Pathology, Shanghai Medical University, Shanghai200032, China)(National Laboratory for Oncogenes and Related Genes, ShanghaiCencer Institute)See invited commentary on page 388.Dynamic changes of typeⅠ,Ⅲand N collagen synthesis and distribution of collagen-producing cells in carbon tetrachloride-induced rat liver fibrosis[J].World Journal of Gastroenterology,1999,5(5):397-403. 被引量:47
  • 2Gao ZL,Li DG,Lu HM,Gu XH.The effect of retinoic acid on Ito cell proliferation and content of DNA and RNA[J].World Journal of Gastroenterology,1999,5(5):443-444. 被引量:13
  • 3Wong S F, Lai L C.The role of TGF beta in human cancers [J]. Pathology,2001 ;33(1 ) :85-92.
  • 4Dunning A M, Ellis P D, McBride S et al. A transforming growth factor betal signal peptide variant increases secretion in vitro and is associated with increased incidence of invasive breast cancer [J]. Cancer Res,2003;63(10): 2610-2615.
  • 5Li Z, Habuchi T, Tsuchiya N et al. Increased risk of prostate cancer and benign prostatic hyperplasia associated with transforming growth factor-beta 1 gene polymorphism at codon10 [J]. Carcinogenesis,2004;25(2):237-240.
  • 6Kim Y J, Lee H S, lm J P et al. Association of transforming growth factorbeta 1 gene polymorphisms with a hepatocellualr carcinoma risk in patients with chronic hepatitis B virus infection [J]. Exp Mol Med,2003;35(3) :196-202.
  • 7Holla L 1, Fassrmnn A,Benes P et al.5 polymorphisms in the transforming growth factor-beta 1 gene (TGF-beta 1) in adult periodontits [J].J Clin Periodontol, 2002; 29(4) : 336-341.
  • 8Fukuchi M,Masuda N,Miyazaki T et al. Decreased Smad4 expression in the transforming growth factor-beta signaling pathway during progression of esophageal squamous cell carcinoma [J]. Cancer,2002;95(4):737-743.
  • 9Tsushima H, Kawat S,Tamura S et al. High levels of transforming growth factor β, in patients with colorectal cancer: association with disease progression [J]. Gastroen terology, 1996; 110(2) :375-382.
  • 10Casson A G, Evans S C, Gillis A et al. Clinical implications of p53 tumor suppressor gene mutation and protein expression in esophageal adenocarcinomas:results of a ten-year prospective study [J]. J Thorac Cardiovasc Surg, 2003; 125(1): 1121-1131.

共引文献14083

同被引文献46

引证文献7

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部